Glenn Thurston Iii. Stebbins
#156,209
Most Influential Person Now
Glenn Thurston Iii. Stebbins's AcademicInfluence.com Rankings
Glenn Thurston Iii. Stebbinsphilosophy Degrees
Philosophy
#8849
World Rank
#12306
Historical Rank
Logic
#5862
World Rank
#7307
Historical Rank
Glenn Thurston Iii. Stebbinsbiology Degrees
Biology
#12055
World Rank
#15504
Historical Rank
Neuroscience
#2004
World Rank
#2060
Historical Rank
Download Badge
Philosophy Biology
Glenn Thurston Iii. Stebbins's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Neuroscience University of California, San Francisco
Why Is Glenn Thurston Iii. Stebbins Influential?
(Suggest an Edit or Addition)Glenn Thurston Iii. Stebbins's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results (2008) (4378)
- Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease (2004) (1771)
- Unified Huntington's disease rating scale: Reliability and consistency (1996) (1393)
- Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan (2007) (1068)
- Depression rating scales in Parkinson's disease: Critique and recommendations (2007) (616)
- How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale (2013) (534)
- White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study (2006) (458)
- Risk factors for nursing home placement in advanced Parkinson's disease (1993) (448)
- Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment (2001) (438)
- Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease (1998) (357)
- Treatment of ADHD in children with tics: a randomized controlled trial. (2002) (351)
- A 12-year population-based study of psychosis in Parkinson disease. (2010) (333)
- Apathy and anhedonia rating scales in Parkinson's disease: Critique and recommendations (2008) (292)
- Rating scales for dystonia: A multicenter assessment (2003) (282)
- Hallucinations in Parkinson disease (2009) (269)
- Mortality and hallucinations in nursing home patients with advanced Parkinson's disease (1995) (264)
- Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model (2005) (261)
- Health‐related quality‐of‐life scales in Parkinson's disease: Critique and recommendations (2011) (245)
- Aging effects on memory encoding in the frontal lobes. (2002) (243)
- Anxiety rating scales in Parkinson's disease: Critique and recommendations (2008) (242)
- Memory encoding in Alzheimer's disease: an fMRI study of explicit and implicit memory. (2005) (242)
- Diffusion Tensor Imaging in Alzheimer’s Disease and Mild Cognitive Impairment (2009) (237)
- Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations (2010) (225)
- Physical therapy and Parkinson's disease (1994) (222)
- Reduced working memory span in Parkinson's disease: Evidence for the role of frontostriatal system in working and strategic memory. (1996) (214)
- Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease (2010) (203)
- Factor structure of the unified Parkinson's disease rating scale: Motor examination section (1998) (198)
- Intact mirror-tracing and impaired rotary-pursuit skill learning in patients with Huntington's disease: evidence for dissociable memory systems in skill learning. (1997) (194)
- The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile (2008) (187)
- Altered cortical visual processing in PD with hallucinations (2004) (184)
- Measurement instruments to assess posture, gait, and balance in Parkinson's disease: Critique and recommendations (2016) (179)
- Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease. (2006) (176)
- Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease. (2016) (172)
- Working and strategic memory deficits in schizophrenia. (1998) (169)
- Intravenous levodopa in hallucinating Parkinson's disease patients (1998) (167)
- Objective changes in motor function during placebo treatment in PD (2000) (164)
- Expanded and independent validation of the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) (2012) (164)
- Scales to assess psychosis in Parkinson's disease: Critique and recommendations (2008) (158)
- GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease (2016) (157)
- Cessation of driving and unsafe motor vehicle operation by dementia patients. (1991) (157)
- Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at‐home testing device (2009) (155)
- Teaching tape for the motor section of the toronto western spasmodic torticollis scale (1997) (154)
- Early dopaminergic drug-induced hallucinations in parkinsonian patients (1998) (152)
- Dysautonomia rating scales in Parkinson's disease: Sialorrhea, dysphagia, and constipation—Critique and recommendations by movement disorders task force on rating scales for Parkinson's disease (2009) (147)
- The malignant course of "benign hallucinations" in Parkinson disease. (2006) (141)
- Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society‐unified Parkinson's disease rating scale scores (2012) (140)
- Gray Matter Atrophy in Patients With Ischemic Stroke With Cognitive Impairment (2008) (139)
- Dystonia rating scales: Critique and recommendations (2013) (131)
- Task force report: Scales for screening and evaluating tremor: Critique and recommendations (2013) (130)
- Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations. (2014) (124)
- Global scales for cognitive screening in Parkinson's disease: Critique and recommendations (2018) (123)
- Predicting Functional Gains in a Stroke Trial (2007) (117)
- Evaluation of a modified inverted walking stick as a treatment for Parkinsonian freezing episodes (1990) (114)
- Switching dopamine agonists in advanced Parkinson’s disease (1999) (111)
- Diagnosing PD‐MCI by MDS task force criteria: How many and which neuropsychological tests? (2015) (108)
- Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease (2013) (105)
- Hallucinations and sleep disorders in PD (2005) (104)
- Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale (2013) (103)
- Estrogen receptor immunoreactivity within subregions of the rat forebrain: neuronal distribution and association with perikarya containing choline acetyltransferase (1999) (101)
- Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations (2010) (99)
- Validation of the MDS‐UPDRS Part I for nonmotor symptoms in Parkinson's disease (2012) (95)
- Clinical differences among mild cognitive impairment subtypes in Parkinson's disease (2012) (95)
- Wearing‐off scales in Parkinson's disease: Critique and recommendations (2011) (92)
- Differential progression of motor impairment in levodopa‐treated Parkinson's disease (2000) (86)
- Risk factors for progression in Parkinson's disease (1988) (85)
- Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off‐state (1999) (85)
- Teaching tape for the motor section of the unified Parkinson's disease rating scale (1995) (84)
- Determinants of quality of life in children with Gilles de la Tourette syndrome (2009) (84)
- Disability Rating Scales in Parkinson's Disease: Critique and Recommendations (2016) (81)
- Age-associated reduction of asymmetry in prefrontal function and preservation of conceptual repetition priming (2009) (80)
- Visual plus nonvisual hallucinations in Parkinson's disease: Development and evolution over 10 years (2011) (79)
- Systematic review of severity scales and screening instruments for tics: Critique and recommendations (2017) (78)
- Use of the national adult reading test to estimate premorbid iq in dementia. (1990) (77)
- HIV-Associated Alterations in Normal-Appearing White Matter: A Voxel-Wise Diffusion Tensor Imaging Study (2007) (76)
- Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies (2008) (76)
- Assuring interrater reliability for the UPDRS motor section: Utility of the UPDRS teaching tape (2004) (76)
- Which dyskinesia scale best detects treatment response? (2013) (75)
- Emerging topics in FXTAS (2014) (71)
- Neuroimaging of White Matter in Aging and Dementia (2007) (70)
- Teaching program for the movement disorder society‐sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS‐UPDRS) (2010) (67)
- fMRI Activation Changes during Successful Episodic Memory Encoding and Recognition in Amnestic Mild Cognitive Impairment Relative to Cognitively Healthy Older Adults (2008) (66)
- Atypical cortical connectivity and visuospatial cognitive impairments are related in children with chromosome 22q11.2 deletion syndrome (2008) (65)
- Are patients with Parkinson’s disease blind to blindsight? (2014) (65)
- Immediate vs. delayed treatment of psychogenic movement disorders with short term psychodynamic psychotherapy: randomized clinical trial. (2014) (64)
- Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease. (2013) (63)
- Differences in MDS‐UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration (2016) (63)
- Delayed recognition memory in Parkinsons disease: a role for working memory? (1999) (62)
- Application of the unified Parkinson's disease rating scale in progressive supranuclear palsy: Factor analysis of the motor scale (2000) (62)
- Longitudinal changes in white matter following ischemic stroke: A three-year follow-up study (2006) (62)
- Plasma -tryptophan/neutral amino acid ratio and dexamethasone suppression in depression (1984) (61)
- Changes in Parahippocampal White Matter Integrity in Amnestic Mild Cognitive Impairment: A Diffusion Tensor Imaging Study (2009) (60)
- A pilot test of pioglitazone as an add-on in patients with relapsing remitting multiple sclerosis (2009) (58)
- The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease. (2013) (57)
- The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension (2011) (56)
- Cognitive profile of LRRK2‐related Parkinson's disease (2015) (55)
- Development and validation of a clinical scale for rating the severity of Blepharospasm (2015) (54)
- Association of memory and cognition in Alzheimer's disease with volumetric estimates of temporal lobe structures. (1996) (54)
- The tools of the trade: A state of the art “How to Assess Cognition” in the patient with Parkinson's disease (2014) (53)
- Analysis of Stereotactic Accuracy in Patients Undergoing Deep Brain Stimulation Using Nexframe and the Leksell Frame (2015) (53)
- I finally see what you see: Parkinson's disease visual hallucinations captured with functional neuroimaging (2014) (52)
- Review of diagnostic instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendations. (2014) (52)
- Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia (2012) (52)
- Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease (2017) (52)
- Efficacy of a patient‐training videotape on motor fluctuations for on‐off diaries in parkinson's disease (1997) (51)
- TikTok Tics: A Pandemic Within a Pandemic (2021) (51)
- Effects of language disturbances on premorbid estimates of IQ in mild dementia. (1990) (50)
- Clinical validation of movement disorder society–recommended diagnostic criteria for Parkinson's disease with dementia (2012) (50)
- Outcome measurement in functional neurological disorder: a systematic review and recommendations (2020) (49)
- Beyond a motor disorder: a prospective evaluation of sleep quality in cervical dystonia. (2014) (48)
- Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients. (2018) (47)
- Impaired Frontostriatal Cognitive Functioning Following Posteroventral Pallidotomy in Advanced Parkinson's Disease (2000) (47)
- Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation (1996) (47)
- Age-related changes in parahippocampal white matter integrity: A diffusion tensor imaging study (2012) (45)
- Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment (2018) (45)
- White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease (2018) (45)
- Cognitive Assessment in Alzheimer's Disease: Cross-Sectional and Longitudinal Perspectives (1986) (44)
- Accuracy of Intraoperative Computed Tomography during Deep Brain Stimulation Procedures: Comparison with Postoperative Magnetic Resonance Imaging (2017) (44)
- Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS. (2014) (44)
- Consensus-Based Attributes for Identifying Patients With Spasmodic Dysphonia and Other Voice Disorders (2018) (44)
- Development of the Comprehensive Cervical Dystonia Rating Scale: Methodology (2015) (43)
- Initial cognitive changes in Parkinson's disease (2018) (42)
- Movement Disorder Society Unified Parkinson Disease Rating Scale experiences in daily living: Longitudinal changes and correlation with other assessments (2013) (41)
- Knowledge gaps and research recommendations for essential tremor. (2016) (41)
- Levodopa stability in solution: Time course, environmental effects, and practical recommendations for clinical use (1996) (41)
- Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations (2016) (39)
- Assessment of Ataxia Rating Scales and Cerebellar Functional Tests: Critique and Recommendations (2020) (38)
- The Parkinson's disease e‐diary: Developing a clinical and research tool for the digital age (2019) (38)
- Selective impairments of memory functioning in unmedicated adults with Gilles de la Tourette's syndrome. (1995) (38)
- Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests (2018) (37)
- Effect of Stereotaxic Intrastriatal Cografts of Autologous Adrenal Medulla and Peripheral Nerve in Parkinson's Disease: Two-Year Follow-up Study (1997) (37)
- Telemedicine vs Office Visits in a Movement Disorders Clinic: Comparative Satisfaction of Physicians and Patients (2018) (37)
- Neuropsychological Dissociation Between Recognition Familiarity and Perceptual Priming in Visual Long-Term Memory (1998) (35)
- Talipexole and adult Gilles de la tourette's syndrome: Double‐blind, placebo‐controlled clinical trial (1994) (35)
- Official Japanese Version of the International Parkinson and Movement Disorder Society–Unified Parkinson's Disease Rating Scale: Validation Against the Original English Version (2014) (35)
- Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations (2016) (34)
- Scales to assess impulsive and compulsive behaviors in Parkinson's disease: Critique and recommendations (2019) (34)
- Effects of pioglitazone on diffusion tensor imaging indices in multiple sclerosis patients (2010) (33)
- Handling missing values in the MDS‐UPDRS (2015) (32)
- Validation study of the hoehn and yahr scale included in the MDS‐UPDRS (2018) (32)
- Review of Severity Rating Scales for Restless Legs Syndrome: Critique and Recommendations (2014) (32)
- Treatment of ADHD in children with tics (2002) (32)
- Atrophy and dysfunction of parahippocampal white matter in mild Alzheimer's disease (2012) (31)
- Failing as doorman and disc jockey at the same time: Amygdalar dysfunction in Parkinson's disease (2016) (30)
- Clinimetric testing of the comprehensive cervical dystonia rating scale (2016) (28)
- Rating scales for cognition in Huntington's disease: Critique and recommendations (2018) (27)
- Effects of head trauma from motor vehicle accidents on Parkinson's disease (1991) (27)
- IPMDS‐Sponsored Scale Translation Program: Process, Format, and Clinimetric Testing Plan for the MDS‐UPDRS and UDysRS (2014) (27)
- Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations (2006) (27)
- Entorhinal cortex volume is associated with episodic memory related brain activation in normal aging and amnesic mild cognitive impairment (2011) (26)
- The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s Disease (2019) (25)
- Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia. (1993) (25)
- Cross‐Cultural Differences of the Non‐Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society–Unified Parkinson's Disease Rating Scale (2017) (25)
- Temporal stability of the Unified Dyskinesia Rating Scale (2011) (24)
- Age-related changes in the mesial temporal lobe: the parahippocampal white matter region (2012) (24)
- Review of quality of life instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendations. (2014) (23)
- Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations (2018) (23)
- Movement Disorder Society–Unified Parkinson's Disease Rating Scale Use in the Covid‐19 Era (2020) (22)
- Predicting white matter targets for direct neurostimulation therapy (2010) (22)
- Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting (2018) (22)
- Regional differences in relationships between apparent white matter integrity, cognition and mood in patients with ischemic stroke (2010) (21)
- Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science (2020) (21)
- Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report (2015) (20)
- Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health‐Related Quality of Life and Caregiver Quality of Life (2018) (20)
- Rating Scales and Performance‐based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations (2018) (20)
- Physical therapy in Parkinson's disease (1995) (19)
- The Progressive Supranuclear Palsy Clinical Deficits Scale (2020) (18)
- Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease (2014) (18)
- Association between antipsychotics and body mass index when treating patients with tics. (2010) (18)
- Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation (2017) (18)
- Therapeutic development paths for cognitive impairment in Parkinson's disease: report of a regulatory roundtable. (2014) (18)
- Parkinson disease and STN-DBS: cognitive effects in GBA mutation carriers. (2022) (18)
- Item Response Theory Analysis of the MDS‐UPDRS Motor Examination: Tremor vs. Nontremor Items (2020) (16)
- Vibration therapy for Parkinson's disease: Charcot's studies revisited. (2012) (16)
- What influences placebo and nocebo responses in Parkinson's disease? (2018) (15)
- Using cognitive pretesting in scale development for Parkinson's disease: the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) example. (2014) (14)
- White matter anisotropy and depression symptoms in patients with HIV. (2008) (14)
- Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations (2018) (14)
- The effect of changes in head posture on the patterns of muscle activity in cervical dystonia (CD) (1998) (13)
- Clinical Rating Scale Development (2012) (12)
- Association of the Fractal Dimension of Retinal Arteries and Veins with Quantitative Brain MRI Measures in HIV-Infected and Uninfected Women (2016) (12)
- Dopamine dysregulation syndrome item from the MDS‐UPDRS (2012) (12)
- Clinimetric Properties of the Fragile X‐associated Tremor Ataxia Syndrome Rating Scale (2019) (12)
- Postural Directionality and Head Tremor in Cervical Dystonia (2020) (11)
- Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale (2018) (11)
- Teaching program for the Unified Dyskinesia Rating Scale (2009) (11)
- Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers (2022) (11)
- Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter study (2017) (10)
- Non‐Motor Fluctuations in Parkinson's Disease: Validation of the Non‐Motor Fluctuation Assessment Questionnaire (2021) (10)
- Determining a dose-effect curve for botulinum toxin in the sternocleidomastoid muscle in cervical dystonia (1994) (10)
- Validation of the Polish version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). (2020) (9)
- Radiological Findings in FXTAS (2010) (8)
- Validizácia slovenskej verzie Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) (2013) (7)
- Measuring Medication Adherence in Parkinson's Disease: A Systematic Review of Contributing Components in Rating Scales (2020) (7)
- MDS-UPDRS use in the COVID era. (2020) (7)
- Gender Effects on HIV-Associated White Matter Alterations: A Voxel-Wise DTI Study (2008) (7)
- An assessment of brain function predicts functional gains in a clinical stroke trial (2007) (7)
- Gender‐, age‐, and race/ethnicity‐based differential item functioning analysis of the movement disorder society–sponsored revision of the Unified Parkinson's disease rating scale (2016) (7)
- Commonalities and Challenges in the Development of Clinical Trial Measures in Neurology (2014) (7)
- The Cortical Basal ganglia Functional Scale (CBFS): Development and preliminary validation. (2020) (6)
- The Parkinson’s Disease Comprehensive Response (PDCORE): a composite approach integrating three standard outcome measures (2020) (6)
- Reliability, feasibility and satisfaction of telemedicine evaluations for cervical dystonia (2020) (6)
- Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale. (2017) (6)
- Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing (2014) (6)
- PSYCHOTIC SYMPTOMS IN PARKINSON'S DISEASE (1997) (6)
- Independent Spanish Validation of the Unified Dyskinesia Rating Scale (2014) (6)
- It's tricky: Rating alleviating maneuvers in cervical dystonia (2020) (6)
- Intraoperative x‐ray to measure distance between DBS leads: A reliability study (2012) (5)
- Head tremor and pain in cervical dystonia (2021) (5)
- The Corpus Callosum Splenium Sign in Fragile X‐Associated Tremor Ataxia Syndrome (2017) (5)
- The effects of cerebral white matter changes on cardiovascular responses to cognitive and physical activity in a stroke population. (2012) (5)
- The Splenium of the Corpus Callosum Sign in Fragile X associated Tremor Ataxia Syndrome (FXTAS) (P2.125) (2015) (5)
- Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of Change (2021) (5)
- Chapter 27 – Neuropsychological Testing (2007) (5)
- Clinimetric Analysis of the Motor Section of the Progressive Supranuclear Palsy Rating Scale: Reliability and Factor Analysis (2016) (4)
- Reliability of the Severity subscale of the revised Toronto Spasmodic Torticollis Rating Scale (TWSTRS-2) (S15.001) (2015) (4)
- Head tremor in cervical dystonia: Quantifying severity with computer vision (2022) (4)
- Experiencing Parkinson’s Disease Psychosis via Virtual Reality Simulation: A Novel and Effective Educational Tool (P1.011) (2016) (4)
- Varenicline for the treatment of postural and gait dysfunction in Parkinson’s disease (PD) (2020) (4)
- Differential item functioning in the Unified Dyskinesia Rating Scale (UDysRS) (2017) (4)
- Development and Validation of the Orthostatic Tremor Severity and Disability Scale (OT‐10) (2020) (4)
- The pathology of hallucinations: one or several points of processing breakdown? (2014) (3)
- Diffusion Tensor Imaging in Parkinson’s Disease (2010) (3)
- Does MDS‐UPDRS Provide Greater Sensitivity to Mild Disease than UPDRS in De Novo Parkinson's Disease? (2021) (3)
- Novel Approach to Movement Disorder Society–Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory Models (2021) (3)
- Validation of the Thai Version of the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (2022) (3)
- New version of the UPDRS: Development methods and working document for field testing (2005) (3)
- Reply: MoCA for cognitive screening in Parkinson's disease: Beware of floor effect (2018) (3)
- Does Raising the Arms Modify Head Tremor Severity in Cervical Dystonia? (2021) (3)
- Determinants of placebo effects. (2020) (3)
- The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease. (2019) (3)
- The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations (2022) (3)
- Risk factors for nursing home placement in advanced Parkinson's disease (1993) (3)
- Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory Modeling (2022) (2)
- Sensory Tricks Are Associated with Higher Sleep-Related Quality of Life in Cervical Dystonia (2019) (2)
- Progression of Parkinson's disease (1989) (2)
- Relationship of Movement Disorders Society–Unified Parkinson's Disease Rating Scale Nonmotor Symptoms to Cognitive Functioning in Patients with Parkinson's Disease (2020) (2)
- It Is as It Was: MDS‐UPDRS Part III Scores Cannot Be Combined with Other Parts to Give a Valid Sum (2022) (2)
- Hold that pose: capturing cervical dystonia's head deviation severity from video (2022) (2)
- High Resolution Diffusion Tensor MRI of Rabbit Tendons and Ligaments at 11.7T (2010) (2)
- Multiple sclerosis: an unexpected cause of senile dementia. (1989) (2)
- Comparison of motor, non-motor, and quality of life phenotype in Black and White patients with Parkinson's disease. (2022) (2)
- A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine‐Rich Repeat Kinase 2 Mutation (2021) (2)
- Clinimetric testing of the new UPDRS (MDS-UPDRS) vs. original version (2007) (2)
- Reply to: Cognitive Effects of Deep Brain Stimulation in GBA‐Related Parkinson's Disease (2022) (2)
- Is Telemedicine the New Normal or Is the Office Visit Still the Movement Disorder Option of Choice? (2021) (2)
- Toward e‐Scales: Digital Administration of the International Parkinson and Movement Disorder Society Rating Scales (2020) (2)
- Cognitive Impairment Screening Scales (2012) (2)
- Missing Data in the Unified Dysksinesia Rating Scale (UDysRS) (2018) (2)
- Application of longitudinal item response theory models to modeling Parkinson’s disease progression (2022) (1)
- P2-231 Voxel-based morphometry contributions to the diagnosis of mild cognitive impairment (2004) (1)
- MDS-Sponsored Scale Translation Program: Process, Format, and Clinimetric Testing Plan for the MDS-UPDRS and UDysRS (P2.052) (2014) (1)
- Validation of the Arabic Version of the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale (2022) (1)
- Comparison of Clock Scoring Methods in Detecting Mild Cognitive Impairment and Dementia in Parkinson's Disease (PD4.008) (2012) (1)
- Tracking Emergence of New Motor and Non-Motor Symptoms Using the MDS-UPDRS: A Novel Outcome Measure for Early Parkinson’s Disease? (2022) (1)
- The stability of carbidopa in solution (1997) (1)
- Validation of the Hebrew Version of the Unified Dyskinesia Rating Scale (2020) (1)
- From Null to Midline: Changes in Head Posture do Not Predictably Change Head Tremor in Cervical Dystonia (2022) (1)
- Apathy , fatigue and quality of life in patients with Parkinson ' s disease (2018) (1)
- Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings (2023) (1)
- Relationship between the MDS-UPDRS and Quality of Life in Parkinson's Disease: a large international multicenter Study (the QUALPD study) (2016) (1)
- Validation of the Finnish Version of the Unified Dyskinesia Rating Scale (2021) (1)
- Telemedicine vs Office visits in a Movement Disorder Specialty Clinic: Comparative Satisfaction of physicians and patients. (P4.003) (2017) (1)
- Hippocampal disconnection due to white matter loss in individuals with amnestic mild cognitive impairment (2005) (1)
- Unified Dyskinesia Rating Scale (2016) (1)
- Sexual orientation and gender identity documentation at an academic movement disorders neurology clinic (2022) (1)
- 182. Development of a rating scale (2015) (1)
- Quality Improvement in Neurology (2021) (1)
- White matter abnormalities as a marker of Parkinson’s disease cognitive impairment: a diffusion tensor imaging study (P3.017) (2015) (1)
- Rating scales for medication adherence in people living with Parkinson's disease: a systematic review protocol. (2021) (1)
- COVID-19 Outcomes in Hospitalized Patients With Neurodegenerative Disease: A Retrospective Cohort Study. (2021) (1)
- MDS‐UPDRS Motor Examination retains its two‐domain profile in both ON and OFF (2022) (1)
- Kinesthetic cells within the subthalamic nucleus and Deep Brain Stimulation for Parkinson's Disease. (2020) (1)
- Erratum: Emerging topics in FXTAS (2015) (1)
- Neuroanatomical correlates of cognitive functioning across the Parkinson's Disease cognitive spectrum (P3.006) (2015) (1)
- Novel approach to MDS‐UPDRS monitoring in clinical trials: Longitudinal Item Response Theory Models (2021) (1)
- The Usefulness of Electromyography (EMG) in Botulinum Toxin Treatment of Cervical Dystonia (1993) (0)
- Criminality in Huntington Disease (2022) (0)
- Responsivity of the Fragile X-Associated Tremor Ataxia Syndrome Rating Scale (P05.034) (2013) (0)
- Papers to Appear in Forthcoming Issues (1999) (0)
- Papers to Appear in Forthcoming Issues (1999) (0)
- Fragile X-associated tremor ataxia syndrome rating scale: Revision and content validity using a mixed method approach (2022) (0)
- Excessive Daytime Sleepiness, Sleep Quality, and Cognitive Impairment in Parkinson's Disease (P06.053) (2012) (0)
- Response to letter by Saenz‐Farret et al. on “Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations” (2017) (0)
- Long-Term Neuropsychological Outcomes of Staged Subthalamic Nuclei Stimulation in Patients with Parkinson's Disease (P02.232) (2012) (0)
- SPECT and fMRI Analysis of Motor and Cognitive Indices of Early Parkinson's Disease: The Relationship of Striatal Dopamine and Cortical Function (2005) (0)
- Cognitive correlations of stroke, white matter disease and brain atrophy after stroke: Preliminary validation of NINDS-VCI harmonization criteria (2009) (0)
- Handling Missing Values in the MDS-UPDRS (P1.195) (2015) (0)
- Placebo Response in Fragile X‐associated Tremor/Ataxia Syndrome (2020) (0)
- P2-065: Volume loss and parahippocampal white matter integrity in amnestic mild cognitive impairment (2008) (0)
- Critical Path for Parkinson's: Catalyzing Innovation for Parkinson's Clinical Trials through Data Sharing and Regulatory Science (2019) (0)
- Expanded and Independent Spanish Validation of the MDS‐Non Motor Rating Scale (2023) (0)
- STABILITY OF LEVODOPA/CARBIDOPA SOLUTIONS. AUTHORS' REPLY (1997) (0)
- Erratum to: Commonalities and Challenges in the Development of Clinical Trial Measures in Neurology (2014) (0)
- History of Hypertension, but Not Measured Blood Pressure, Is Associated with Cortical Volume and White Matter Integrity in Middle-Aged Women with HIV (P1.097) (2016) (0)
- In Support of Electronic Versions of Movement Disorder Society Rating Scales (2021) (0)
- MRI validation of the NINDS-CSN proposed neuropsychological assessment protocol for vascular cognitive impairment (2009) (0)
- Discriminant validity for the proposed NINDS-CSN harmonization vascular cognitive impairment neuropsychological assessment protocols (2009) (0)
- IC-P1-062: fMRI activation changes during successful episodic memory encoding and recognition in amnestic mild cognitive impairment relative to cognitively healthy older adults (2008) (0)
- Varenicline for the Treatment of Imbalance in Parkinson’s Disease (1838) (2020) (0)
- Corpus Callosum Volume Is Decreased in Parkinson’s Disease (P4.102) (2016) (0)
- Validation of the Polish version of the Unified Dyskinesia Rating Scale (UDysRS). (2021) (0)
- Unified Dyskinesia Rating Scale: Candidate for Official Designation of FDA Designation as Qualified Clinical Outcome Assessment (P1.023) (2016) (0)
- Immediate Versus Delayed Treatment of Psychogenic Movement Disorders with Short Term Psychodynamic Psychotherapy (P02.246) (2012) (0)
- Relationship between the MDS-UPDRS and Quality of Life : a large international multicenter study of 3206 patients (2018) (0)
- White Matter Hyperintensities Successfully Differentiate Parkinson's Disease Patients with and without Cognitive Impairment (P06.050) (2013) (0)
- Clinimetric Testing of the Modules for the Comprehensive Cervical Dystonia Rating Scale (CCDRS) (S27.004) (2014) (0)
- New version of the UPDRS (MDS-UPDRS): Factor analysis (2008) (0)
- Diffusion tensor imaging changes in the corpus callosum and cognitive impairment in Parkinson’s disease (P4.029) (2017) (0)
- IC-P2-129: Volume loss and parahippocampal white matter integrity in amnestic-MCI (2008) (0)
- Resolving Missing Data from the Movement Disorder Society Unified Parkinson's Disease Rating Scale: Implications for Telemedicine (2022) (0)
- Erratum: Emerging topics in FXTAS (2015) (0)
- Treatment of RRMS patients with the PPARgamma agonist actos: results of a phase I trial (2007) (0)
- Summing MDS-UPDRS Parts 1 + 2 (Non-motor and Motor Experience of Daily Living): The Patient's Voice. (2023) (0)
- P1-301: fMRI activation changes during successful episodic memory encoding and recognition in amnestic mild cognitive impairment relative to cognitively healthy older adults (2008) (0)
- University of Groningen Apathy , fatigue and quality of life in patients with Parkinson ' s disease (2017) (0)
- MEMORY FUNCTIONING IN PARKINSON'S DISEASE: THE EFFECT OF AGE OF ONSET ON HIGH SPEED MEMORY SCANNING. (1987) (0)
- Reply: Hoehn and Yahr stage 3 and Postural stability item in the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale (2018) (0)
- Successful use of the Unified Dyskinesia Rating Scale regardless of PD- or dyskinesia-duration. (2019) (0)
- Not Just Another Pretty Picture (2005) (0)
- Phenotypic Differences Between African American and Caucasian Parkinson’s Disease Patients (P5.356) (2016) (0)
- Sensory Tricks Are Associated with Higher Sleep-Related Quality of Life in Cervical Dystonia (2019) (0)
- Movement Disorder Society Unified Parkinson's Disease Rating Scale Motor Examination Retains Its 2‐Domain Profile in Both On and Off States (2022) (0)
- Stress Levels Correlate with Severity of Cervical Dystonia (P01.234) (2012) (0)
- Determining Optimal Cutoff Scores and Neuropsychological Tests for the Diagnosis of Mild Cognitive Impairment in Parkinson's Disease (S37.003) (2014) (0)
- Hallucinations And Dementia In Parkinson’s Disease: Clinically Related But Structurally Distinct (P5.257) (2014) (0)
- Preface. (2020) (0)
- MRI validation of the NINDS-CSN proposed neuropsychological assessment protocol for vascular cognitive impairment (2009) (0)
- Abstract 2322: Validity of the NINDS-CSN VCI Neuropsychological Protocols is Supported in a Sample of Ischemic Stroke Patients (2012) (0)
- Letters to the Editor (1997) (0)
- Fatigue in Parkinson's Disease (P06.052) (2012) (0)
- Non-Motor Fluctuations in Parkinson's Disease (PD): Development and Validation of the Non-Motor Fluctuation Assessment Instrument (NoMoFA) (2020) (0)
- Cerebral Small Vessel Disease: Nonconventional MR techniques for imaging cerebral small vessel disease (2014) (0)
- Cognitive correlations of stroke, white matter disease and brain atrophy after stroke: Preliminary validation of NINDS-VCI Harmonization criteria (2009) (0)
- Who Should Answer? How to Assess Psychosis in Demented Patients with Parkinson’s Disease or Lewy Body Dementia. (P8-11.010) (2023) (0)
- The Rush Video‐Based Tic Rating Scale‐Revised : a practice‐oriented revision (2023) (0)
- Understanding visual hallucinations: a new synthesis. (2023) (0)
- Rating Scales for Medication Adherence in Parkinson's Disease: A Systematic Review for Critique and Recommendations (2022) (0)
- No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187) (2013) (0)
- Cross‐Cultural Differences in Patient Perceptions of Dyskinesia in Parkinson's Disease (2023) (0)
- Parkinson’s Disease Medication Adherence Scale: Conceptualization, Scale Development, and Clinimetric Testing Plan (2022) (0)
- Comparison of Movement Disorder Society Criteria for Parkinson's Disease Dementia with Routine Clinical Neuropsychological Testing (PD4.006) (2012) (0)
- CLASSIFICATION OF PRISON INMATES ACCORDING TO PRISON RULES AND REGULATIONS (ENVIRONMENT) (1985) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Glenn Thurston Iii. Stebbins?
Glenn Thurston Iii. Stebbins is affiliated with the following schools:
